Marotta Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2M | Buy |
74,706
+12,776
| +21% | +$1.06M | 1.24% | 27 |
|
|
2025
Q1 | $6.12M | Sell |
61,930
-1,266
| -2% | -$125K | 1.2% | 25 |
|
|
2024
Q4 | $5.78M | Buy |
63,196
+1,266
| +2% | +$116K | 1.21% | 24 |
|
|
2024
Q3 | $6.12M | Sell |
61,930
-2,738
| -4% | -$271K | 1.2% | 25 |
|
|
2024
Q2 | $6.02M | Sell |
64,668
-456
| -0.7% | -$42.4K | 1.24% | 24 |
|
|
2024
Q1 | $6.18M | Sell |
65,124
-3,449
| -5% | -$327K | 1.28% | 25 |
|
|
2023
Q4 | $6.12M | Buy |
68,573
+611
| +0.9% | +$54.6K | 1.31% | 27 |
|
|
2023
Q3 | $4.96M | Buy |
67,962
+3,313
| +5% | +$242K | 1.15% | 28 |
|
|
2023
Q2 | $5.38M | Buy |
+64,649
| New | +$5.38M | 1.2% | 27 |
|
|
2022
Q4 | $5.02M | Buy |
60,540
+4,575
| +8% | +$380K | 1.21% | 30 |
|
|
2022
Q3 | $4.44M | Sell |
55,965
-1,157
| -2% | -$91.8K | 1.16% | 30 |
|
|
2022
Q2 | $4.37M | Buy |
57,122
+13,682
| +31% | +$1.05M | 1.08% | 30 |
|
|
2022
Q1 | $3.9M | Buy |
43,440
+4,748
| +12% | +$427K | 0.91% | 30 |
|
|
2021
Q4 | $4.33M | Buy |
38,692
+1,540
| +4% | +$172K | 0.98% | 28 |
|
|
2021
Q3 | $4.67M | Buy |
37,152
+1,171
| +3% | +$147K | 1.13% | 27 |
|
|
2021
Q2 | $4.98M | Buy |
35,981
+4,173
| +13% | +$578K | 1.2% | 27 |
|
|
2021
Q1 | $4.36M | Buy |
31,808
+4,513
| +17% | +$618K | 1.11% | 26 |
|
|
2020
Q4 | $3.84M | Buy |
27,295
+3,484
| +15% | +$490K | 1.01% | 28 |
|
|
2020
Q3 | $2.65M | Buy |
+23,811
| New | +$2.65M | 0.81% | 32 |
|